Azienda Ospedaliera per l Emergenza Cannizzaro

Catania 95126

1 studies enrolling now · 4 studies all time

What they study most

Endometrial Neoplasms, Ovarian Cancer, Solid Cancer, Ulcerative Colitis and Crohn's Disease

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed